Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 256,147 | 164,903 | 202,125 | 207,638 | 194,430 |
| Cost of Goods | 4,061 | 2,883 | 2,545 | 4,596 | 3,433 |
| Gross Profit | 252,086 | 162,020 | 199,580 | 203,042 | 190,997 |
| Operating Expenses | 210,847 | 212,504 | 195,638 | 193,419 | 164,755 |
| Operating Income | 41,300 | -49,601 | 4,487 | 10,219 | 26,675 |
| Other Income | 4,631 | 4,886 | 5,423 | 5,024 | 5,017 |
| Pre-tax Income | 45,931 | -44,715 | 9,910 | 15,243 | 31,692 |
| Income Tax | 2,944 | -12,954 | -14,378 | -4,425 | -3,457 |
| Net Income Continuous | 42,987 | -31,761 | 24,288 | 19,668 | 35,149 |
| Net Income | $42,987 | $-31,761 | $24,288 | $19,668 | $35,149 |
| EPS Basic Total Ops | 0.40 | -0.30 | 0.24 | 0.19 | 0.33 |
| EPS Basic Continuous Ops | 0.41 | -0.30 | 0.23 | 0.19 | 0.34 |
| EPS Diluted Total Ops | 0.36 | -0.30 | 0.20 | 0.16 | 0.29 |
| EPS Diluted Continuous Ops | 0.36 | -0.30 | 0.20 | 0.16 | 0.29 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.30 | 0.20 | 0.16 | 0.29 |
| EBITDA(a) | $42,163 | $-49,003 | $-134 | $10,696 | $27,144 |